Provided by Tiger Fintech (Singapore) Pte. Ltd.

Apellis Pharmaceuticals Inc.

21.47
+0.74003.57%
Post-market: 21.770.3000+1.40%19:57 EDT
Volume:6.49M
Turnover:133.98M
Market Cap:2.72B
PE:-11.77
High:21.80
Open:21.00
Low:19.25
Close:20.73
52wk High:35.72
52wk Low:16.10
Shares:126.53M
Float Shares:78.12M
Volume Ratio:1.67
T/O Rate:8.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8245
EPS(LYR):-1.5970
ROE:14.10%
ROA:5.13%
PB:6.77
PE(LYR):-13.44

Loading ...

Oct 27, 2020

Major Issues Report

8-K - Current report
Jul 30, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 01, 2020

Major Issues Report

8-K - Current report
May 13, 2020

Major Issues Report

8-K - Current report
May 07, 2020

Major Issues Report

Current report, items 1.01, 2.03, 3.02, 8.01, and 9.01
Apr 29, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 06, 2020

Major Issues Report

Current report, item 5.02
Feb 27, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 05, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 28, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 09, 2020

Major Issues Report

Current report, items 1.01 and 8.01
Jan 07, 2020

Major Issues Report

Current report, item 2.02
Jan 07, 2020

Major Issues Report

Current report, item 8.01
Nov 05, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 07, 2019

Major Issues Report

Current report, items 5.02 and 9.01